A recent study from the same group analyzed over 2200 transcriptomes from 146 independent hPSC lines and found that 22% of the samples had cancer-related mutations, with 64% having TP53 mutations, that provided a selective advantage, disrupted target gene expression, and affected cellular differentiation [38]. The gene discussed is TP53; the disease is cancer.